Rofecoxib (pronounced /roʊfəˈkɒksɪb/)
is a nonsteroidal anti-inflammatory
drug (NSAID) developed by Merck & Co.
to treat osteoarthritis, acute pain
conditions, and dysmenorrhoea.
Rofecoxib was approved as safe
and effective by the Food and Drug
Administration (FDA) on May 20, 1999
and was subsequently marketed under
the brand name Vioxx, Ceoxx and Ceeoxx
is a nonsteroidal anti-inflammatory
drug (NSAID) developed by Merck & Co.
to treat osteoarthritis, acute pain
conditions, and dysmenorrhoea.
Rofecoxib was approved as safe
and effective by the Food and Drug
Administration (FDA) on May 20, 1999
and was subsequently marketed under
the brand name Vioxx, Ceoxx and Ceeoxx
No comments:
Post a Comment